• You are here:
  • Grants
  • Research Grants

We are no longer accepting applications for the 2020 Research Grants. The cycle for the 2021 IUGA Research Grants is scheduled to open in the first quarter of 2021.

The IUGA offers both Basic Science and Clinical Research Grants to fund original research by an IUGA member or trainee. The research grants are designed to fund development of the proposed research project including all materials and testing, statistical analyses, and services required to complete the research.

The grant cycle opens in the spring and typically closes prior to the Annual Meeting. All submitted applications will be reviewed, scored, and commented upon by members of the IUGA Research and Development Committee. Applicants will be notified of the outcome via email. Award recipients will be announced to the membership via email and recipient names will be included on the IUGA website.

Rachel High headshot

"Support from the IUGA clinical research grant made it possible to carry out our study on higher neural changes in women treated with oral medication for overactive bladder. Funding was required to carry out functional neuroimaging in our study protocol, which the IUGA grant has made possible. Results from this study will be of great value to many different medical communities (primary care, urology, urogynecology, neurology, etc.) who treat overactive bladder with oral medication."
-Rachel High, 2019 IUGA Research Grant Recipient


Two grants will be awarded:

  • USD 10,000 for a clinical patient-oriented research project
  • USD 10,000 for a laboratory-based/basic science research project

The initial USD 5,000 payment will be made upon award of the grant, and the remaining USD 5,000 will be paid upon receipt and review of the 6-month Interim Report. Ethical approval must be received, if applicable, by the IUGA Office before any funds will be released. Grants will only be paid to an institution and not to an individual.


  • Any IUGA member in good standing is eligible to apply for the grant program.
  • Applicant must remain at the same institution for the entire funding period.

Submission Instructions

A complete grant application must be submitted via email to the IUGA Office (This email address is being protected from spambots. You need JavaScript enabled to view it.) by the published deadline. All required application documents (listed below) except CVs must be submitted as a single PDF with documents in the order listed below. CVs should be submitted as separate attachments. Only complete applications that include all required materials and that explicitly follow these instructions will be forwarded to the Research and Development Committee for review. An IUGA Office staff member will review each application for completeness before forwarding it to the Research and Development Committee for review and has the authority to disqualify an application if all required information, signatures, related documents, and/or page or word limit requirements are not followed. Applications are reviewed blindly.

Required Application Documents

  • Application (download form here)
  • Structured Abstract (limit 200 words)
  • Proposed start and finish dates
  • Background Review (do not include institution name as applications are blindly reviewed)
    • Describe the sponsoring institution
    • List previous research activities and accomplishments, especially as they relate to the proposed research project or your ability to complete the proposed research project.
    • Describe the goals and objectives of previous research as it relates to the proposed research project, as this provides a context for the work you plan to undertake.
    • Describe the service areas and populations served. Include a description of laboratory facilities, if applicable.
  • Research Protocol
    • Specific aims
    • Background/significance
    • Methodology
    • Ethics and Patient Consent (if applicable)
    • Ethics and Animal Studies (if applicable)
    • References (limit to 20)
  • Budget
    • Please indicate how the funds will be allocated in detail, in US dollars.
    • If the study is being funded by another source, this must be disclosed in the budget section, as well as on the Application.
    • Salaries for the Principal Investigator(s) and any co-investigator(s) are not supported.
    • Funding may include statistical analyses, tech support (i.e. sonographer), laboratory studies, diagnostic studies (i.e. post-treatment urodynamics), mailing and postage for questionnaires or other related material, and patient vouchers for transportation, meals, etc.
    • Funding will not include travel, computer, meeting fees and related expenses, equipment, manuscript preparation costs, indirect costs such as university overhead or IRB fees.
  • Evaluation Criteria and Progress
    • Describe what measures will be used to evaluate the progress of the research study.
    • Describe what records and information will be maintained to allow measurement of progress.
    • Has this research application been reviewed/had input from patient representatives?
  • IRB Approval (if applicable)
    • Provide a copy of the IRB approval letter. If IRB approval is pending at the time of application submission, indicate the status of the IRB approval and an approximate date of approval. If approved, please include the IRB approval number. If exempt, please explain.
  • Appendices (if applicable)
    • Include any data collection forms, questionnaires, or other study-related materials.
    • Flowchart of study with timelines if possible.
  • Supporting Documentation
    • Provide at least two (2) letters of Support from the department/institution head and collaborators, such as those individuals supplying patient referrals.
    • A brief CV limited to 2 pages with only relevant information included.

Questions should be directed to the IUGA Office at This email address is being protected from spambots. You need JavaScript enabled to view it..

Award Requirements

Additional Funding

Award recipients are required to disclose if/when additional funding is received from another source for the same project. If recipient receives duplicate funding for the same project after receiving funding from IUGA, the recipient may be required to return the excess amount to IUGA, up to the maximum amount of the IUGA award.

Interim Report

Grant recipients are required to submit a 6-month interim report (from the date of the first grant payment) reporting the progress of the research study to date. The Interim Report Form is available here. Interim Reports must be submitted electronically to the IUGA Office (This email address is being protected from spambots. You need JavaScript enabled to view it.). All interim reports will be reviewed by the Research and Development Committee Chair and Research Grant Chair. More information may be requested prior to releasing the final grant payment.

Final Report

Grant recipients are required to submit a final report stating the results of the research study and an itemized budget showing how the funds were used, including providing receipts of paid items, where applicable. The final report is due to the IUGA Office (This email address is being protected from spambots. You need JavaScript enabled to view it.) one month following the completion of the research study award period (7 months following the Interim Report). The Final Report Form is available here.

Presentation & Publication

Grant recipients are required to submit an abstract of their completed research study for presentation at the following IUGA Annual Meeting, and to submit a completed manuscript for publication to the International Urogynecology Journal. All publications and presentations must acknowledge funding from IUGA via an IUGA Research Grant.

Past IUGA Research Grant Recipients


  • Basic Science: Lindsey Burnett, Intravesical Gentamicin in Adult Women with Recurrent Urinary Tract Infection: The Urinary Microbiome and Metabolomic Profile
  • Clinical: Gabriel Ganyaglo, Cohort Study of Pelvic Organ Prolapse in Two Ghanaian Communities


  • Basic Science: May Alarab, The Effect of Local Estrogen Therapy on the Microbiome Composition and Relative Abundance in the Urine of Postmenopausal Women with/without Urinary Tract Infections
  • Clinical: Rachel High, Higher Neural and Cognitive Changes Following Anitcholinergic versus Beta 3 Agonist versus Placebo Treatments in Patients with Overactive Bladder: A Multicenter Randomized Control Pilot Trial


  • Basic Science: Zhuoran Chen, Refractory Urge Incontinence: A Battle Between Proinflammatory and Anti-inflammatory Cytokines?
  • Clinical: Vatche Minassian, Urinary Microbiome and Inflammatory Response in Postmenopausal Women with Urgency Urinary Incontinence Before and After Anticholinergic Treatment


  • Basic Science: John Occhino & Marina Walther-Antonio, Evaluation of the Vaginal and Rectal Microbiome in Patients with Rectovaginal Fistula
  • Clinical: Catherine Hudson & Pamela Escobar Smith, A Pilot Randomized Controlled Trial of Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function



  • IUGA ASTORA Women’s Health Clinical Research Grant: Rajeev Ramanah, Evaluating the Biomechanical Efficacy of Transvaginal Mesh Anterior and Apical Prolapse Repair Using Finite Element Modeling in Living Women
  • IUGA Cogentix Medical Clinical Research Grant: Cheryl Iglesia, Treatment of Refractory Overactive Bladder with Onabotulinumtoxin A vs PTNS: TROOP Trial



  • Basic Science: Gamal Ghoneim, Voiding Dysfunction and GABA Modulation in a Mouse Model of Cyclophosphamide-included Cystitis
  • Basic Science: Jennifer Rohn, Quiescent Intracellular Bacteria as Long-term Reservoirs in Recurrent Urinary Tract Infection (UTI) and Lower Urinary Tract Symptoms (LUTS) in Women
  • Clinical: Uduak Andy, Clinical and Biochemical Evidence of Neurogenic Inflammation in Women with Urinary Urgency
  • Clinical: Jane Manning, Prospective Randomized Double Blind Study into the Effectiveness of Intravaginal Lyrica® Cream for Chronic Vaginal Pain


  • Basic Science: Michel Cosson, Biomechanical Modeling of the Pelvic Lesions Induced in Obstetrics Impact on Pelvic Floor Static
  • Clinical: M.M.E. Lakeman, Observational Study to Evaluate the Effects of Prolapse Surgery Using Synthetic Mesh on Vaginal Innervation, Genital Response and the Influence of These Changes on Sexual Well-being
  • Least-developed Countries: Barry O’Reilly, The Role of Cytokines in Overactive Bladder


  • Basic Science: Sunil Balgobin, Repeat Injury to the External Anal Sphincter: Contractile Properties and Morphologic Changes Over Time
  • Clinical: Rufus Cartwright, Genome Wide Association Study of Urinary Incontinence in Women


  • J Deprest, D Rizk, D De Ridder, HA Amer, E Mazza, Experimental Evaulation of the Effect of Age + Hormonal Status on Surgical Repair of Fascial Defects
  • C Walsh, K Moore, Y Cheng, Low Count Bacteruria and its Relationship to ATP Release in Refractory Detrusor Overactivity


  • H Harvie, J Shea, L Arya, JS Schwartz, Health-related Quality of Life: Utility Preference for Pelvic Organ Prolapse
  • D Tincello, R Elliot, AH Taylor, J Willets, C Maynce, The Role and Significance of the Sweet Taste Receptor Isoform T1R3 in the Rodent and Human Bladder


  • M Ho, N Bhatia, N Gonzalez-Cadavid, M Ferrini, I Kovanecz, Adipose-derived Stem Cell Therapy for Defective Pelvic Support and Stress Urinary Incontinence
  • J Malone-Lee, R Khasriya, R Lunawat, A Clinical Exploration of the Pathophysiology of an Inflammatory Response Associated with the Overactive Bladder